Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division

Molecular Endocrinology

Volumn 15, Issue 11, 2001, Pages 1870-1879

  Wang, Z ^a   Yu, R ^a   Melmed, S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CYCLE G2 PHASE; CELL DIVISION; CELL STRAIN 3T3; CENTROMERE; FEMALE; HYPOPHYSIS TUMOR; HYPOPLASIA; MALE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SISTER CHROMATID; SPLEEN; TESTIS; THROMBOCYTOPENIA; THYMUS HYPERPLASIA;

EID: 0034748340     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.11.0729     Document Type: Article

References (44)

1. Genes involved in the control of cellular proliferative potential
2. Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control
3. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
4. Effects of an Rb mutation in the mouse
5. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
6. Splitting the chromosome: Cutting the ties that bind sister chromatids
7. An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast
8. Fission yeast Cut1 and Cut2 are essential for sister chromatid separation, concentrate along the metaphase spindle and form large complexes
9. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis
10. Separation of sister chromatids in mitosis requires the Drosophila pimples product, a protein degraded after the metaphase/anaphase transition
11. The bimB3 mutation of Aspergillus nidulans uncouples DNA replication from the completion of mitosis
12. Isolation and characterization of a pituitary tumor-transforming gene (P-TTG)
13. Characterization of the murine pituitary tumor transforming gene (PTTG) and its promoter
14. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG)
15. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis
16. Pituitary tumor transforming gene (PTTG) transforming and transactivation activity
17. Identification of c-myc as a down-stream target for pituitary tumor-transforming gene
18. Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: Evidence from live cell imaging
19. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product
20. Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function
21. Securin is required for chromosomal stability in human cells
22. Genomic instability in Gadd45a-deficient mice
23. Identification of Xenopus SMC protein complexes required for sister chromatid cohesion
24. Postovulatory ageing of mouse oocytes in vivo and premature centromere separation and aneuploidy
25. Bloom syndrome: A mendelian prototype of somatic mutational disease
26. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens
27. Involvement of Brca2 in DNA repair
28. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
29. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27kip1 activity
30. INK4d-deficient mice are fertile despite testicular atrophy
31. Control of spermatogenesis in mice by the cyctin D-dependent kinase inhibitors p18Ink4c and p19Ink4d
32. Tumor induction and tissue atrophy in mice lacking E2F-1
33. Infertility associated with incomplete spermatogenic arrest and oligozoospermia in Egr4-deficient mice
34. Spermiogenesis deficiency in mice lacking the Trf2 gene
35. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin
36. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development
37. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development
38. Defective platelet activation in G alpha(q)-deficient mice
39. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
40. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia
41. Molecular cytogenetic delineation of the critical deleted region in the 5q-syndrome
42. The human thrombin receptor gene and the 5q-syndrome
43. Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis
44. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts